The WCBP Symposium series was created to address issues at the interface of analytical development and global regulatory for biotechnology-derived health intervention products. The goal was to provide a forum for discussing the latest bioanalytical methods and their practical application to biotechnology pharmaceuticals and other health related products.
Our AQS3proTM was a cutting edge addition to the new and existing technologies being showcased. This included both method and instrumental advances that are used for product characterization, process development, in-process analysis and validate release and stability testing.
Interested in learning more about how the AS3pro fits into the technology landscape?
Biopharm International magazine recently published a roundtable with scientists experienced in biophysical characterization techniques on the range of technologies available for protein studies.
We look forward to seeing you at an upcoming conference.